MA27171A1 - Dihydro-thia-phenanthrene-darbonyl-guanidines, procede de production desdites substances et leur utilisation en tant que medicament ou produit de diagnostic, et medicament contenant lesdites substances - Google Patents
Dihydro-thia-phenanthrene-darbonyl-guanidines, procede de production desdites substances et leur utilisation en tant que medicament ou produit de diagnostic, et medicament contenant lesdites substancesInfo
- Publication number
- MA27171A1 MA27171A1 MA27802A MA27802A MA27171A1 MA 27171 A1 MA27171 A1 MA 27171A1 MA 27802 A MA27802 A MA 27802A MA 27802 A MA27802 A MA 27802A MA 27171 A1 MA27171 A1 MA 27171A1
- Authority
- MA
- Morocco
- Prior art keywords
- substances
- medicament
- darbonyl
- guanidines
- thia
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 2
- 239000000126 substance Substances 0.000 title 2
- 239000012502 diagnostic product Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/10—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms two oxygen atoms and one sulfur atom, e.g. cyclic sulfates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10204989A DE10204989A1 (de) | 2002-02-07 | 2002-02-07 | Dihydro-thia-phenanthren-carbonyl-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27171A1 true MA27171A1 (fr) | 2005-01-03 |
Family
ID=27618378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA27802A MA27171A1 (fr) | 2002-02-07 | 2004-07-27 | Dihydro-thia-phenanthrene-darbonyl-guanidines, procede de production desdites substances et leur utilisation en tant que medicament ou produit de diagnostic, et medicament contenant lesdites substances |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1474414B1 (fr) |
| JP (1) | JP4410564B2 (fr) |
| KR (1) | KR20040096555A (fr) |
| CN (1) | CN1319963C (fr) |
| AR (1) | AR038393A1 (fr) |
| AT (1) | ATE380805T1 (fr) |
| AU (1) | AU2003208337A1 (fr) |
| BR (1) | BR0307495A (fr) |
| CA (1) | CA2475093A1 (fr) |
| CO (1) | CO5601008A2 (fr) |
| DE (2) | DE10204989A1 (fr) |
| HR (1) | HRP20040721A2 (fr) |
| HU (1) | HUP0402595A2 (fr) |
| MA (1) | MA27171A1 (fr) |
| MX (1) | MXPA04007476A (fr) |
| NO (1) | NO20043717L (fr) |
| NZ (1) | NZ534536A (fr) |
| PE (1) | PE20030963A1 (fr) |
| PL (1) | PL370271A1 (fr) |
| RS (1) | RS69204A (fr) |
| RU (1) | RU2306311C2 (fr) |
| TW (1) | TWI268927B (fr) |
| WO (1) | WO2003066620A1 (fr) |
| ZA (1) | ZA200406015B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200614995A (en) | 2004-11-10 | 2006-05-16 | Nicholas Piramal India Ltd | Tricyclic guanidine derivatives as sodium-proton exchange inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60262887A (ja) * | 1984-06-11 | 1985-12-26 | Mitsubishi Chem Ind Ltd | 液晶組成物 |
| GB8505756D0 (en) * | 1985-03-06 | 1985-04-11 | Erba Farmitalia | Tricyclic dibenzo condensed derivatives |
| US4948806A (en) * | 1988-03-30 | 1990-08-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| DE19601303A1 (de) * | 1996-01-16 | 1997-07-17 | Boehringer Ingelheim Kg | Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln |
| JP2002542291A (ja) * | 1999-04-23 | 2002-12-10 | ブリストル−マイヤーズ スクイブ カンパニー | ジ環式アシルグアニジン・ナトリウム／プロトン交換抑制剤および方法 |
| DE10001879A1 (de) * | 2000-01-19 | 2001-07-19 | Aventis Pharma Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
2002
- 2002-02-07 DE DE10204989A patent/DE10204989A1/de not_active Withdrawn
-
2003
- 2003-01-23 AU AU2003208337A patent/AU2003208337A1/en not_active Abandoned
- 2003-01-23 RS YU69204A patent/RS69204A/sr unknown
- 2003-01-23 BR BR0307495-1A patent/BR0307495A/pt not_active IP Right Cessation
- 2003-01-23 CN CNB038035502A patent/CN1319963C/zh not_active Expired - Fee Related
- 2003-01-23 CA CA002475093A patent/CA2475093A1/fr not_active Abandoned
- 2003-01-23 HR HR20040721A patent/HRP20040721A2/hr not_active Application Discontinuation
- 2003-01-23 JP JP2003565993A patent/JP4410564B2/ja not_active Expired - Fee Related
- 2003-01-23 PL PL03370271A patent/PL370271A1/xx not_active Application Discontinuation
- 2003-01-23 NZ NZ534536A patent/NZ534536A/en unknown
- 2003-01-23 EP EP03706373A patent/EP1474414B1/fr not_active Expired - Lifetime
- 2003-01-23 WO PCT/EP2003/000653 patent/WO2003066620A1/fr not_active Ceased
- 2003-01-23 KR KR10-2004-7012241A patent/KR20040096555A/ko not_active Withdrawn
- 2003-01-23 HU HU0402595A patent/HUP0402595A2/hu unknown
- 2003-01-23 DE DE50308787T patent/DE50308787D1/de not_active Expired - Lifetime
- 2003-01-23 MX MXPA04007476A patent/MXPA04007476A/es active IP Right Grant
- 2003-01-23 RU RU2004126854/04A patent/RU2306311C2/ru not_active IP Right Cessation
- 2003-01-23 AT AT03706373T patent/ATE380805T1/de not_active IP Right Cessation
- 2003-01-30 TW TW092102087A patent/TWI268927B/zh not_active IP Right Cessation
- 2003-02-05 AR ARP030100363A patent/AR038393A1/es unknown
- 2003-02-05 PE PE2003000136A patent/PE20030963A1/es not_active Application Discontinuation
-
2004
- 2004-07-27 MA MA27802A patent/MA27171A1/fr unknown
- 2004-07-28 ZA ZA200406015A patent/ZA200406015B/en unknown
- 2004-08-06 CO CO04076743A patent/CO5601008A2/es not_active Application Discontinuation
- 2004-09-06 NO NO20043717A patent/NO20043717L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI268927B (en) | 2006-12-21 |
| CN1630649A (zh) | 2005-06-22 |
| PL370271A1 (en) | 2005-05-16 |
| CO5601008A2 (es) | 2006-01-31 |
| EP1474414A1 (fr) | 2004-11-10 |
| ZA200406015B (en) | 2005-11-14 |
| ATE380805T1 (de) | 2007-12-15 |
| JP4410564B2 (ja) | 2010-02-03 |
| JP2005517015A (ja) | 2005-06-09 |
| KR20040096555A (ko) | 2004-11-16 |
| HK1073656A1 (en) | 2005-10-14 |
| HRP20040721A2 (en) | 2005-06-30 |
| MXPA04007476A (es) | 2004-11-10 |
| TW200404792A (en) | 2004-04-01 |
| NO20043717L (no) | 2004-11-03 |
| CA2475093A1 (fr) | 2003-08-14 |
| CN1319963C (zh) | 2007-06-06 |
| RU2306311C2 (ru) | 2007-09-20 |
| DE50308787D1 (de) | 2008-01-24 |
| NZ534536A (en) | 2006-02-24 |
| HUP0402595A2 (hu) | 2005-04-28 |
| RS69204A (sr) | 2006-12-15 |
| RU2004126854A (ru) | 2006-01-27 |
| WO2003066620A1 (fr) | 2003-08-14 |
| AR038393A1 (es) | 2005-01-12 |
| BR0307495A (pt) | 2004-12-28 |
| DE10204989A1 (de) | 2003-08-21 |
| PE20030963A1 (es) | 2004-01-12 |
| AU2003208337A1 (en) | 2003-09-02 |
| EP1474414B1 (fr) | 2007-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2048178A4 (fr) | Produit de réaction d'estérification, gélifiant contenant le produit et préparation cosmétique les contenant | |
| MA27366A1 (fr) | Nouveaux derives de thiophenylglycoside, methodes pour leur production, medicaments contenant lesdits composes et leur utilisation | |
| FR2852957B1 (fr) | Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament | |
| MA27147A1 (fr) | 4-phenyltetrahydro-isoquinoleines substituees, procede pour leur preparation, leur utilisation en tant que medicament, et medicament les contenant | |
| DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| MA27252A1 (fr) | Diphenylazetidinones substituees, leur procede de preparation, medicaments contenant ces composes et leur utilisation | |
| MA26532A1 (fr) | Derives d'amines cycliques, compositions pharmaceutiques les contenant, procede pour les preparer, et leur utilisation et tant que principe pharmaceutique agissant contre les maladies respiratoires. | |
| WO2004075823A3 (fr) | Derives de benzimidazole et d’imidazo-pyridine ayant une addinite pour les recepteurs des melanocortines et leur utilisation en tant que medicament | |
| FR2906475B1 (fr) | Unite medicale pour le prelevement,le calibrage,la dilution et/ou l'injection d'un produit radioactif injectable | |
| MA27206A1 (fr) | Azetidinones substituees par des groupements acides, procede pour leur preparation, medicaments contenant lesdits composes et utilisation de ceux-ci. | |
| CU23473B7 (es) | Medicamentos que contienen clorhidrato de vardenafilo trihidrato | |
| CY1110558T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| BRPI0410611A (pt) | processo para a formação de um produto em bastão, sólido, antitranspirante ou desodorante, auto-suportado | |
| NO20043252L (no) | Fremgangsmate for fremstilling av tissueprodukt inneholdende karboksylerte cellelosefibre | |
| EP2062971A4 (fr) | Adénovirus chimérique, son procédé de production et produit pharmaceutique utilisant ledit adénovirus | |
| FR2840307B1 (fr) | Nouvelles molecules multimeriques, leur procede de preparation, et leur utilisation pour la preparation de medicaments | |
| PT1124841E (pt) | Fenil-alcenoil-guanidinas processo para a sua preparacao sua utilizacao como medicamentos ou meios de diagnostico bem como composicao farmaceutica que as contem | |
| DE602004014805D1 (de) | Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten | |
| EP2111862A4 (fr) | Produit pharmaceutique destiné à la prévention et au traitement de la démence d'alzheimer | |
| EP1539718A4 (fr) | Derive de 1,2,4-triazole, son procede de preparation et composition pharmaceutique le contenant | |
| MA27204A1 (fr) | Thiophenes substitues, procede de preparation de ceux-ci, utilisation en tant que medicament ou reactif diagnostique, et medicament contenant ceux-ci | |
| EP1624859A4 (fr) | Procede de preparation de compositions thermoformees contenant des liants de polymere acrylique, des posologies pharmaceutiques et leurs procedes de preparation | |
| ATE381929T1 (de) | Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe | |
| NO20062824L (no) | 1,3-Difenylprop-2-en-1-on-avledete forbindelser, fremgangsmater for fremstilling derav, samt anvendelse av samme | |
| FR2885129B1 (fr) | Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation. |